American Trust’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,366
Closed -$1.29M 256
2024
Q1
$1.29M Sell
14,366
-3,253
-18% -$276K 0.11% 92
2023
Q4
$1.4M Sell
17,619
-1,438
-8% -$108K 0.1% 88
2023
Q3
$1.36M Sell
19,057
-4,360
-19% -$326K 0.1% 91
2023
Q2
$1.8M Sell
23,417
-373
-2% -$28.9K 0.13% 106
2023
Q1
$1.79M Buy
23,790
+291
+1% +$21.6K 0.12% 105
2022
Q4
$1.85M Sell
23,499
-1,529
-6% -$115K 0.17% 101
2022
Q3
$1.76M Sell
25,028
-1,401
-5% -$110K 0.15% 101
2022
Q2
$2.12M Sell
26,429
-2,775
-10% -$217K 0.17% 96
2022
Q1
$2.21M Buy
+29,204
New +$2.31M 0.15% 100

Other funds holding CL

American Trust's CL Position: Q2 2024 in Review

American Trust sold out of Colgate-Palmolive (CL) in Q2 2024, closing a stake of 14,366 shares — an estimated $1.29M sold.

American Trust first reported a position in CL in Q1 2022 and held it in 9 quarters. The position peaked at $2.21M in Q1 2022. 1,819 funds tracked by Wall St. Rank hold CL as of Q2 2024.

  • American Trust reported no remaining Colgate-Palmolive position as of Q2 2024 after selling out during the quarter.
  • American Trust sold 14,366 Colgate-Palmolive shares in Q2 2024, an estimated $1.29M.
  • American Trust first reported a position in Colgate-Palmolive in Q1 2022 and held it in 9 quarters.
  • American Trust's Colgate-Palmolive position peaked at $2.21M in Q1 2022.
  • 1,819 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2024.

Based on American Trust's 13F filing for Q2 2024, filed 12 Sep 2024.